Position in NVS
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$822,936
+$16,264 QoQ
Shares Held
5,251
-0.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.52%
of 13F equity value
Holder Rank
#689
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Banco de Sabadell, S.A holds $14,969,128 across 7 Drug Manufacturers - General names. NVS ranks #7 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,248 | $5,095,179 | |
| 2 | JNJ |
Johnson & Johnson
|
12,879 | $3,270,879 | |
| 3 | AMGN |
Amgen Inc
|
6,877 | $2,490,299 | |
| 4 | MRK |
Merck & Co., Inc.
|
11,969 | $1,538,016 | |
| 5 | NVO |
Novo Nordisk A S
|
18,330 | $878,740 | |
| 6 | SNY |
Sanofi
|
20,466 | $873,079 | |
| 7 | NVS |
Novartis AG
This page
|
5,251 | $822,936 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $822,936 | 5,251 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $806,672 | 5,281 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $781,722 | 5,670 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $733,532 | 5,720 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $839,325 | 6,936 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $769,546 | 6,903 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $666,768 | 6,852 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $818,482 | 7,116 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $884,363 | 8,307 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $785,931 | 8,125 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $823,511 | 8,156 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $832,909 | 8,177 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $855,010 | 8,473 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $783,564 | 8,517 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $697,546 | 7,689 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $470,501 | 6,190 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $594,837 | 7,037 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $633,730 | 7,222 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $584,824 | 6,686 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $494,360 | 6,045 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $581,837 | 6,377 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $508,264 | 5,946 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $572,717 | 6,065 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $493,671 | 5,677 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $480,806 | 5,505 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $508,963 | 6,173 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||